OKYO Pharma (NASDAQ: OKYO) Announces Randomized Segment Now Underway in Phase 2 Clinical Trial of Topical Ocular OK-101 for Dry Eye Disease

Trial designed with a two-week run-in period to reduce the well-known placebo effect in trials involving pain component Top-line data from trial anticipated in Q4, 2023 LONDON and NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (DED) […]

AccuStem Sciences, Inc. (OTCQB: ACUT) Announces Collaboration Agreement with University Hospitals

LONDON and PHOENIX, Ariz., June 06, 2023 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, today announced the establishment of a joint clinical collaboration agreement with University Hospitals. Per the terms of this agreement, University Hospitals will provide tissue samples with clinical […]

Laser Photonics (NASDAQ:LASE) Announces New CleanTech Customer in the Aerospace Market

ORLANDO, FL / ACCESSWIRE / June 6, 2023 / Laser Photonics Corporation (NASDAQ:LASE), (“LPC”), a leading global developer of CleanTech laser systems for laser cleaning and other material applications, today announced it received an order from Thomas Instrument, a leading manufacturer of complex, critical aerospace components and winches, for its first CleanTech Laser Blasting System. Peter Evans, […]

Announcing Amesite (NASDAQ: AMST) Founder and CEO, Dr. Ann Marie Sastry as Opening Keynote at CSO’s Future of Cybersecurity Summit on June 8, 2023

DETROIT, June 06, 2023 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announced today its Founder and CEO, Dr. Ann Marie Sastry will give the opening keynote address at CSO’s Future of Cybersecurity Summit on June 8, 2023 at 11:40 […]

Tiziana Life Sciences (Nasdaq: TLSA) Announces Reduction in Microglial Activation in a Total of 5 Out of 6 Intranasal Foralumab Expanded Access Patients with Non-Active Secondary Progressive Multiple Sclerosis

Results confirm positive signal previously reported in the first two Expanded Access patients who both subsequently demonstrated clinical improvements Phase 2a trial in na-SPMS on track to begin in Q3 2023 KOL webinar with Howard L. Weiner, M.D., Chairman of Tiziana’s Scientific Advisory Board and Co-Director of the Ann Romney Center for Neurologic Diseases at […]

Brüush (NASDAQ:BRSH) to Present at the Gravitas 4th Los Angeles Summit

VANCOUVER, BC / ACCESSWIRE / May 31, 2023 / Bruush Oral Care Inc. (NASDAQ:BRSH) (the “Company”), a direct-to-consumer leader in the oral care category, announced today that Aneil Manhas, Founder & CEO, will be presenting at the Gravitas 4th Los Angles Summit taking place at The Beverly Hills Hotel from Sunday, June 4th to Tuesday, June 6th, […]

TRNR (Interactive Strength Inc. d/b/a FORME) (NASDAQ: TRNR) to Present at LD Micro Conference on June 7, 2023 in Los Angeles

Presentation to be webcast at 12:00 p.m. Pacific Time on June 7th Austin, Texas–(Newsfile Corp. – June 1, 2023) – Interactive Strength Inc. d/b/a FORME (NASDAQ: TRNR) (“FORME” or “the Company”), maker of premium smart home gyms and provider of virtual personal training services, announces that Trent Ward, Co-founder and CEO, will present at the […]

Splash Beverage Group (NYSE American: SBEV) Comments on Delayed Filing of 10-Q

FORT LAUDERDALE, FL, May 31, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, today announced it had received a notice from the NYSE Regulation of noncompliance with the NYSE American continued listing standards as a result of the Company’s delayed filing of […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.